Interview with Liss Cairns from Plan Institute - RDSP Awareness Month
💜 RDSP Awareness Month is almost over , but it’s not too late to learn about the benefits of a Registered Disability Savings Plan (RDSP)...
top of page
NEWS & MEDIA
News
PHA Canada
Sep 11
PHA Canada Advocates for Fair Access: September Submission to PMPRB
PHA Canada is proud to announce our latest submission to the Patented Medicines Pricing Review Board (PMPRB) this September. As the...
PHA Canada
Sep 5
Sotatercept (WINREVAIR®) Authorized in Canada for PAH Treatment
Merck has announced that WINREVAIR® (sotatercept) is now authorized for use in Canada in combination with standard pulmonary arterial...
PHA Canada
Jul 22
Uncovering Major Inequities in PH Care Across Canada
A new investigation, "A Canadian Initiative: Exploring Adult Pulmonary Hypertension," highlights critical issues such as diagnostic...
PHA Canada
May 13
Sotatercept is now listed on Health Canada's website
We are pleased to announce that sotatercept, a new drug for patients diagnosed with pulmonary arterial hypertension (PAH), is now listed...
Dr. Sanjay Mehta
May 5
Doctors need the right tools to treat patients well, especially for rare diseases
This article originally appeared in The Hills Times on May 6, 2024 Have you ever tried to fix something without the right tool? If you...
PHA Canada
May 5
Dr. Jason Weatherald Discusses the Burden of PAH on the PHaware Podcast
Tune in to the latest episode of the PHaware podcast, where Dr. Jason Weatherald, a pulmonologist at the University of Alberta, delves...
PHA Canada
Apr 21
Disparities in BC's Public Drug Plan
A recent report sheds light on the critical need for British Columbia to bolster its Public Drug Coverage. Over the past five years, BC...
PHA Canada
Mar 26
The FDA has granted approval for the medication sotatercept
The US Food and Drug Administration (FDA) has granted approval for the medication sotatercept, a significant milestone in the treatment...
PHA Canada
Mar 24
Canada Disability Benefit Update
On June 22nd, 2023, a significant milestone was achieved as the federal government enacted Bill C-22, officially establishing the Canada...
CTV News / Jo-Anne Mainwood, Patient, Ottawa
Nov 24, 2023
CTV News - Ottawa school teacher living with rare Pulmonary Arterial Hypertension
Click here to watch Jo-Anne Mainwood interview on CTV News Ottawa --------- Jo-Anne Mainwood has been living with Pulmonary Arterial...
PHA Canada
Nov 13, 2023
Winnipeg City News - Raising Awareness for an incurable lung disease
Click here to watch Ella's interview on Winnipeg City News --------- After getting a second lease on life following a successful lung...
PHA Canada
Sep 27, 2023
The Path to Reconciliation
Each year, September 30 marks the National Day for Truth and Reconciliation. The day honours survivors of the residential school system,...
PHA Canada
Apr 16, 2023
PHA Canada Welcomes Federal Government Investment to Support Access to Rare Disease Drugs
The Pulmonary Hypertension Association of Canada Welcomes Federal Government Investment to Support Access to Rare Disease Drugs...
PHA Canada
Jan 31, 2023
Nova Scotia Formulary Update - February 2023
Nova Scotia published an update to their Formulary, click here to read it
PHA Canada
Jan 8, 2023
PEI made Opsumit available through Public Funding
We are excited to announce that PEI has joined the list of provinces to have taken action and made Opsumit available through public...
bottom of page